News

May 23, 2018

Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials

News

Imagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will be tested in a clinical trial later this year, according to ... Read more

May 21, 2018

Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds

News

A shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer heart-related adverse effects, a Phase 3 clinical trial found. The results ... Read more

May 18, 2018

Program Offering Financial Incentives Encourages Breast Cancer Patients to Exercise More, Study Finds

News

Physical exercise may help breast cancer survivors overcome many of the side effects associated with cancer therapy, but studies show that up to 70% of patients don’t exercise enough. So ... Read more

May 16, 2018May 16, 2018

Breast Cancer ‘Screening Pill’ Could Be on the Horizon, Mice Study Shows

News

Researchers have developed a pill that marks tumors and lights them up when exposed to infrared light, which could potentially replace mammography in the future, a study in mice has ... Read more

May 14, 2018May 14, 2018

Study Discovers Mutations That Cause Resistance to Lynparza, Similar Therapies

News

Researchers have identified mutations in the poly (ADP-ribose) polymerase (PARP) gene that cause resistance to the cancer therapy Lynparza (olaparib) and other PARP inhibitors. These mutations could help physicians predict which cancer ... Read more

May 11, 2018

OncoSec, Merck Partner to Test Immunotherapy Combo in Phase 2 Trial for Triple-negative Breast Cancer

News

OncoSec Medical and Merck have joined efforts to conduct a Phase 2 trial evaluating the safety and effectiveness of ImmunoPulse IL-12 in combination with Keytruda (pembrolizumab) for the treatment of ... Read more

May 9, 2018May 9, 2018

Poor Prognosis for Breast Cancers Diagnosed After Negative Screening Mammography

News

While occurring at low rates, breast cancer cases diagnosed after a negative mammography screening are linked to poorer prognosis compared to those diagnosed after a positive mammogram, an observational study ... Read more

May 7, 2018May 7, 2018

Possible Reasons Why Tyverb/Tykerb Fails as Breast Cancer Monotherapy Explored in Study

News

Lapatinib, an approved medicine for advanced breast cancer available under the brand names Tyverb in Europe and Tykerb in the U.S., can sometimes cause breast cancer cells to grow under ... Read more

May 4, 2018

Short, Targeted Radiation Therapy a Good Option for Early Stage Breast Cancer, Phase 3 Trial Shows

News

The quality of life of women treated with a targeted form of radiation therapy, called accelerated partial breast irradiation (APBI), is similar to those who get the standard whole-breast radiation ... Read more

May 2, 2018

ADC Therapeutics Halts ADCT-502 Development, Phase 1 Trial for HER2-positive Cancers

News

ADC Therapeutics has halted the development of ADCT-502, an investigational treatment candidate for HER2-positive solid cancers, and terminated its Phase 1 trial after it failed to show sufficient patient benefit, ... Read more